November 19, 2024

Wide Variation in SGLT2i Use Across U.S. Hospitals

Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.

Conexiant

November 19, 2024

Lilly Pill Lowers Lp(a) Up to 86%: Study

Reuters

November 18, 2024

Revised AF Guidelines for Dialysis Patients

"The components of the CHA2DS2-VASc score are so prevalent in HD patients with AF that most qualify for OAC if the guidelines are applied" - an observation from the study that challenges conventional risk assessment approaches for this high-risk population.

Conexiant

November 18, 2024

NSAIDs Double Bleeding Risk in VTE Patients

A recent study found that patients taking NSAIDs concurrently with oral anticoagulants had more than twice the bleeding risk compared with patients only taking anticoagulants.

Conexiant

November 15, 2024

FDA Recall of Vessel Harvesters Adds to Shortage

FDA warns of serious injury risks with VasoView HemoPro 1.5, including silicone detachment leading to open surgery in some cases—17 injuries reported, 3 with unretrieved fragments.

Conexiant

November 13, 2024

Unique Genetic Risks Found for Aortic Stenosis

Conexiant

November 12, 2024

How Immune Cells Sabotage the Heart in Duchenne Muscular Dystrophy

New research highlights macrophages’ role in disrupting the heart's nerve communication, offering potential targets for therapy.

Conexiant

November 11, 2024

Cardiac Patients Sought Sex Advice, Found Silence

While 76% of cardiac patients reported sexual health affecting their mood and well-being, only 5% received counseling on the topic, according to new survey data presented at AHA Scientific Sessions 2024.

Conexiant

November 07, 2024

FDA Approves New Heart Device for AF

Varipulse is a pulsed field ablation system.

Reuters